A Review of Blood Substitutes: Examining The History, Clinical Trial Results, and Ethics of Hemoglobin-Based Oxygen Carriers
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The complications associated with acquiring and storing whole blood for transfusions have launched substantial efforts to develop a blood substitute. The history of these efforts involves a complicated mixture of science, ethics, and business. This review focuses on clinical trials of the three hemoglobin-based oxygen carriers (HBOC) that have progressed to Phase II or III clinical trials: He-mAssist (Baxter; Deerfield, IL, US), PolyHeme (Northfield; Evanston, IL, US), and Hemopure (Biopure; Cambridge, MA, US). Published animal studies and clinical trials carried out in a perioperative setting have demonstrated that these products successfully transport and deliver oxygen, but all may induce hypertension and lead to unexpectedly low cardiac outputs. Overall, these studies suggest that HBOCs resulted in only modest blood saving during and after surgery, no improvement in mortality and an increased incidence of adverse reactions. To date, the results from these perioperative studies have not led to regulatory approval. All three companies instead chose to focus their efforts on large trials of trauma patients in the pre-hospital setting.Baxter abandoned the development of HemAssist after a trial in the U.S. was prematurely halted when the first 100 patients showed significantly increased mortality rates as compared to patients treated with blood products. Northfield's PolyHeme trial demonstrated a non-significant trend towards increased mortality and a very modest reduction in the subsequent need for blood. The testing of Biopure's Hemopure for trauma patients has been halted for several years because of FDA concerns over trial design and study justification. Ethical concerns have also been raised regarding the design and implementation of all HBOC clinical trials.Thus, the available evidence suggests that HemAssist, Polyheme, and Hemopure are associated with a significant level of cardiovascular dysfunction. The next generation of HBOCs remains under development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natanson, C., Kern, S. J., Lurie, P., Banks, S. M., & Wolfe, S. M. (2008) · JAMA · doi:10.1001/jama.299.19.jrv80007 · Cited by 622
Blood Transfusion: An Independent Risk Factor for Postinjury Multiple Organ Failure
Moore, F. A. (1997) · Archives of Surgery · doi:10.1001/archsurg.1997.01430300062013 · Cited by 562
Gould, S. A., Moore, E. E., Hoyt, D. B., Burch, J. M., Haenel, J. B., Garcia, J., DeWoskin, R., & Moss, G. S. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00095-7 · Cited by 339
Controlled Safety Study of a Hemoglobin-Based Oxygen Carrier, DCLHb, in Acute Ischemic Stroke
Saxena, R., Wijnhoud, A. D., Carton, H., Hacke, W., Kaste, M., Przybelski, R. J., Stern, K. N., & Koudstaal, P. J. (1999) · Stroke · doi:10.1161/01.str.30.5.993 · Cited by 228 · cited 1×
“Normal saline was used as the control.(29) The researchers administered HemAssist in 12 doses of 25, 50 or 100 mg/kg over 72 hours, resulting in an increase in mean arterial pressure from 113±14 mmHg to 134±20 mmHg, versus no increase in saline controls.”
MethodClinical Experience with Hemoglobin-Saline Solutions
Amberson, W. R., Jennings, J. J., & Rhode, C. M. (1949) · Journal of Applied Physiology · doi:10.1152/jappl.1949.1.7.469 · Cited by 210 · cited 1×
“Despite these observations, the group performed clinical trials using a product containing hemoglobin in lactated Ringer’s solution, which unfortunately produced significant renal dysfunction in 5 of 14 patients.(7) Amberson et al.”
MethodDunne, J. R., Malone, D. L., Tracy, J. K., & Napolitano, L. M. (2004) · Surgical Infections · doi:10.1089/sur.2004.5.395 · Cited by 185 · cited 1×
“Thus, trauma itself, along with transfusions, can cause cytokine release, including systemic inflammatory response.(3) However, as time elapses after trauma has occurred, a patient’s immune function will become”
BackgroundJahr, J. S., Mackenzie, C., Pearce, L. B., Pitman, A., & Greenburg, A. G. (2008) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e318173a93f · Cited by 174 · cited 1×
“Biopure recently published the results of their Phase III study evaluating Hemopure’s ability to reduce or eliminate perioperative transfusion in orthopedic surgical patients.(42) The study included 688 patients randomized to receive either Hemopure or PRBCs.”
BackgroundKasper, S., Walter, M., Grüne, F., Bischoff, A., Erasmi, H., & Buzello, W. (1996) · Anesthesia & Analgesia · doi:10.1097/00000539-199611000-00006 · Cited by 139 · cited 3×
“Northfield reported that PolyHeme was devoid of the vasoconstrictive effects that was a noted side effect of the other HBOCs.20 Northfield reasoned that SFH-P did not result in the vasoconstrictive effects because the polymerized hemoglobin was too large to extravasate into the interstitial space, thus resulting in on…”
BackgroundLaMuraglia, G. M., O’Hara, P. J., Baker, W. H., Naslund, T. C., Norris, E. J., Li, J., & Vandermeersch, E. (2000) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(00)90161-7 · Cited by 132 · cited 1×
“Another intraoperative study evaluated 72 patients undergoing infrarenal aortic reconstruction, randomized in a 2 to 1 ratio to receive either Hemopure or red blood cell transfusions.(38) Patients in the Hemopure group received 60 g of Hemopure as an initial transfusion, with up to 3 additional doses (30 g each) admin…”
Method
Cited by
The Redox Activity of Hemoglobins: From Physiologic Functions to Pathologic Mechanisms
Reeder, B. J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2974 · Cited by 189
“Many comprehensive reviews are available on the viability, clinical trials, and suspected problems of blood substitutes, and reading is recommended (3, 5, 39, 56, 287).”
Blood substitutes: why haven’t we been more successful?
Alayash, A. I. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2014.02.006 · Cited by 179
“The effects of infusion of early preparations of SFH in animals and humans are well documented [8].”
Background
Metadata
- Authors
- Chen, J.-Y., Scerbo, M., & Kramer, G.
- Venue
- Clinics
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 64
- Issue
- 8
- Pages
- 803-813
- ISSN
- 1807-5932 (ISSN-L)
- OpenAlex
- W2161491970
- Cited by
- 216
- References
- 16
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review of Blood Substitutes: Examining The History, Clinical Trial Results, and Ethics of Hemoglobin-Based Oxygen Carriers. https://app.cochat.ai/papers/10.1590/s1807-59322009000800016
- The paper
- Chen, J.-Y., Scerbo, M., & Kramer, G. (2009). A Review of Blood Substitutes: Examining The History, Clinical Trial Results, and Ethics of Hemoglobin-Based Oxygen Carriers. Clinics. https://doi.org/10.1590/s1807-59322009000800016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.